Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/30014
Title: | Current regulatory approaches for accessing potential COVID-19 therapies | Authors: | Halimi, Vesa Daci, Armond Stojanovska, Simona Panovska Stavridis, Irina Stevanovic, Milena Filipce, Venko Grozdanova, Aleksandra |
Issue Date: | 16-May-2020 | Publisher: | Informa UK Limited | Journal: | Journal of Pharmaceutical Policy and Practice | Abstract: | <jats:title>Abstract</jats:title><jats:p>This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.</jats:p> | URI: | http://hdl.handle.net/20.500.12188/30014 | DOI: | 10.1186/s40545-020-00222-6 |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.